Investor · Fund
European Life Science Venture
European Life Science Venture is a real estate fund domiciled in the Netherlands, with $1.63 bn of gross assets, managed by AXA REIM SGP, one of its 3 funds in the data.
Other funds of AXA REIM SGP
2 more funds managed by AXA REIM SGP, which has $10.4 bn of regulatory assets under management across all asset classes.
- AXA Core Europe Fund S.C.S., SICAV-SIF$6.22 bn
- Development Venture IV$0.56 bn
Facts
| Fact | Value | Source |
|---|---|---|
| Name in the source | EUROPEAN LIFE SCIENCE VENTURE | SEC adviser reports (Form ADV) · Public domain · checked 24 Oct 2026 |
| Location | Netherlands | SEC adviser reports (Form ADV) · Public domain · checked 24 Oct 2026 |
| Manager | AXA REIM SGP | SEC adviser reports (Form ADV) · Public domain · checked 24 Oct 2026 |
| Assets under management | $1.63 bn (as of 28 Mar 2024) | SEC adviser reports (Form ADV) · Public domain · checked 24 Oct 2026 |
| Strategy | real estate | SEC adviser reports (Form ADV) · Public domain · checked 24 Oct 2026 |
Looking to co-invest with European Life Science Venture, or to sell to it? Tell us; introductions are private.
Data on this page
- U.S. Securities and Exchange Commission. SEC adviser reports (Form ADV), Public domain.